Javascript must be enabled to continue!
Exploring the Intersectionality of Marital Status and Sex on Survival Outcomes in Non-Hodgkin’s Lymphoma
View through CrossRef
Abstract
Introduction
Non-Hodgkin’s Lymphoma (NHL) remains a significant public health concern with notable disparities in survival outcomes. Sex and marital status are two critical social determinants that influence both cancer-specific survival (CSS) and overall survival (OS). Prior studies suggest that women with NHL face poorer survival outcomes compared to men, and marital status modulates survival, with married individuals demonstrating better outcomes. However, the interplay between sex and marital status on NHL survival has not been thoroughly examined.
Objective
To investigate the combined effects of sex and marital status on CSS and OS in NHL patients.
Methodology
A retrospective cohort study was conducted using SEER registry data spanning 2000 to 2020. Individuals aged 18–85 diagnosed with NHL were included. Cox regression models assessed the interaction between sex and marital status on CSS and OS, adjusting for covariates such as age, race, household income, cancer stage, and treatment modalities. Predicted probabilities of mortality and the differences in sex effects across marital status categories were estimated using interaction terms and linear combinations.
Results
A total of 291,608 patients were included, with females accounting for 54.6% of the cohort. Sex disparities were observed across marital status groups. Married women exhibited a significantly higher probability of overall mortality than married men (9.26, 95% CI: 7.61–10.92, p < 0.001). The disparity was most pronounced among single individuals, where women had a 22.93-unit higher probability of overall mortality compared to men (95% CI: 18.49–27.37, p < 0.001). Similarly, widowed women had higher probabilities of mortality than widowed men (13.10, 95% CI: 10.08–16.11, p < 0.001). Cancer-specific mortality followed a similar pattern, with single women experiencing the greatest disparity compared to single men (8.44, 95% CI: 6.21–10.68, p < 0.001). Comparisons of effects between marital status groups revealed that single individuals exhibited a 13.67-unit greater disparity in overall mortality than married individuals (95% CI: 10.26–17.07, p < 0.001).
Conclusion
This study underscores the significant influence of sex and marital status on survival outcomes in NHL patients. Women face higher cancer-specific and overall mortality risks across all marital status categories. Marital status modifies these disparities, with marriage conferring a survival advantage, particularly for men. These findings highlight the need for targeted interventions to address sex and social disparities in NHL outcomes, emphasizing the importance of social support and tailored survivorship care.
Key Points
Women with NHL have higher overall and cancer-specific mortality than men, with the greatest disparity seen in single individuals.
Marriage reduces survival disparities, benefiting men most, while single and widowed women face the highest mortality risks.
Title: Exploring the Intersectionality of Marital Status and Sex on Survival Outcomes in Non-Hodgkin’s Lymphoma
Description:
Abstract
Introduction
Non-Hodgkin’s Lymphoma (NHL) remains a significant public health concern with notable disparities in survival outcomes.
Sex and marital status are two critical social determinants that influence both cancer-specific survival (CSS) and overall survival (OS).
Prior studies suggest that women with NHL face poorer survival outcomes compared to men, and marital status modulates survival, with married individuals demonstrating better outcomes.
However, the interplay between sex and marital status on NHL survival has not been thoroughly examined.
Objective
To investigate the combined effects of sex and marital status on CSS and OS in NHL patients.
Methodology
A retrospective cohort study was conducted using SEER registry data spanning 2000 to 2020.
Individuals aged 18–85 diagnosed with NHL were included.
Cox regression models assessed the interaction between sex and marital status on CSS and OS, adjusting for covariates such as age, race, household income, cancer stage, and treatment modalities.
Predicted probabilities of mortality and the differences in sex effects across marital status categories were estimated using interaction terms and linear combinations.
Results
A total of 291,608 patients were included, with females accounting for 54.
6% of the cohort.
Sex disparities were observed across marital status groups.
Married women exhibited a significantly higher probability of overall mortality than married men (9.
26, 95% CI: 7.
61–10.
92, p < 0.
001).
The disparity was most pronounced among single individuals, where women had a 22.
93-unit higher probability of overall mortality compared to men (95% CI: 18.
49–27.
37, p < 0.
001).
Similarly, widowed women had higher probabilities of mortality than widowed men (13.
10, 95% CI: 10.
08–16.
11, p < 0.
001).
Cancer-specific mortality followed a similar pattern, with single women experiencing the greatest disparity compared to single men (8.
44, 95% CI: 6.
21–10.
68, p < 0.
001).
Comparisons of effects between marital status groups revealed that single individuals exhibited a 13.
67-unit greater disparity in overall mortality than married individuals (95% CI: 10.
26–17.
07, p < 0.
001).
Conclusion
This study underscores the significant influence of sex and marital status on survival outcomes in NHL patients.
Women face higher cancer-specific and overall mortality risks across all marital status categories.
Marital status modifies these disparities, with marriage conferring a survival advantage, particularly for men.
These findings highlight the need for targeted interventions to address sex and social disparities in NHL outcomes, emphasizing the importance of social support and tailored survivorship care.
Key Points
Women with NHL have higher overall and cancer-specific mortality than men, with the greatest disparity seen in single individuals.
Marriage reduces survival disparities, benefiting men most, while single and widowed women face the highest mortality risks.
Related Results
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Introduction:
The incidence of lymphoma has been increasing over the past several decades, with data showing an estimated annual percentage change of 0.56%. There...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Liệu pháp điều trị trúng đích trong u lympho không Hodgkin
Liệu pháp điều trị trúng đích trong u lympho không Hodgkin
U lympho là bệnh lý ác tính dòng lympho thường gặp nhất trong huyết học, bao gồm u lympho Hodgkin và u lympho không Hodgkin. Trong đó, u lympho không Hodgkin chiếm đa số (80 - 85%)...
Macrophages and Mast Cells Infiltration Are Biomarkers of Primary Refractory Hodgkin's Lymphoma
Macrophages and Mast Cells Infiltration Are Biomarkers of Primary Refractory Hodgkin's Lymphoma
Abstract
Abstract 3881
Classical Hodgkin's lymphoma is a highly curable lymphoma and about 80% of patients can be cured with modern treatment strategi...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Pediatric Lymphoma Incidence at Children's Hospital Benghazi from 2014 to 2023
Pediatric Lymphoma Incidence at Children's Hospital Benghazi from 2014 to 2023
Background: Malignant lymphoma is caused by the neoplastic growth of lymphocytes and can manifest itself diffusely or in one or more lymph node. Hodgkin lymphoma and non-Hodgkin ly...

